Shusuke Akamatsu - Concepedia

Author

Shusuke Akamatsu

Also Known As

Akamatsu Shusuke, Akamatsu, Shusuke, Kei Mizuno, S Akamatsu, S. Akamatsu, SHUSUKE AKAMATSU, Shusuke Akamatsu, Susuke Akamatsu, Yu Wang

306

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Kyoto University Akita University Kyoto University Hospital RIKEN Center for Integrative Medical Sciences The University of Tokyo

About

Shusuke Akamatsu is an author at Kyoto University specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	20	1.1K
2	Biochemistry	4	4	154
3	Natural Sciences	2	2	109
4	Engineering	1	1	286
5	Public Health	1	1	61

Shusuke Akamatsu

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer Shusuke Akamatsu, Alexander W. Wyatt, Dong Lin, Cell Reports	2015	294
Association of a novel long non‐coding RNA in <i>8q24</i> with prostate cancer susceptibility Suyoun Chung, Hidewaki Nakagawa, Motohide Uemura, Cancer Science EngineeringGeneticsGenetic EpidemiologyPathologyGenomics	2010	286
Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population Ryo Takata, Shusuke Akamatsu, Michiaki Kubo, Nature Genetics Genome-wide Association StudyUrologyGeneticsGenetic EpidemiologyCancer Genomics	2010	282
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer Takayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, Scientific Reports	2019	72
Association of Missense Polymorphism in<i>HSD3B1</i>With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone Masaki Shiota, Shintaro Narita, Shusuke Akamatsu, JAMA Network Open GeneticsGenetic EpidemiologyHuman PolymorphismGenetic MedicineClinical Genetics	2019	61
Plasma Low-Molecular-Weight Proteome Profiling Identified Neuropeptide-Y as a Prostate Cancer Biomarker Polypeptide Koji Ueda, Ayako Tatsuguchi, Naomi Saichi, Journal of Proteome Research Proteomic TechnologyUrologyBiochemistryPsa TestMedicine	2013	60
Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy‐naïve castration‐resistant prostate cancer: The Kyoto‐Baltimore collaboration Naoki Terada, Benjamin L. Maughan, Shusuke Akamatsu, International Journal of Urology	2017	59
12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population Ryo Takata, Atsushi Takahashi, Masashi Fujita, Nature Communications	2019	59
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies Yuki Kita, Akihiro Hamada, Ryoichi Saito, British Journal of Cancer	2019	59
Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer Shusuke Akamatsu, Masashi Kubota, Ryuji Uozumi, European Urology Oncology Novel Prognostic ModelSurgical OncologyUrologyGenitourinary CancerMedicine	2018	55

Page 1